ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 04 May 2015
Last Applicant/ Owned by
Suite 2050
Dallas
TX
75201
Serial Number
85322909 filed on 17th May 2011
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
SUPERCLEAN
Medicines, namely, biologic, anti-cancer DNA and RNA preparations, for use in the treatment of cancer; veterinary and medicinal preparations, namely, plasmid containing lipolexes, anti-cancer DNA preparations, and plasmid based therapeutic preparations, for use in the treatment of cancer, and for use in genetic therapy; pharmaceutical preparations and pharmaceutical substances for gene therapy; bi Read More
Classification Information
Class [005]
Pharmaceutical Products
Medicines, namely, biologic, anti-cancer DNA and RNA preparations, for use in the treatment of cancer; veterinary and medicinal preparations, namely, plasmid containing lipolexes, anti-cancer DNA preparations, and plasmid based therapeutic preparations, for use in the treatment of cancer, and for use in genetic therapy; pharmaceutical preparations and pharmaceutical substances for gene therapy; biological preparations for the treatment of cancer
Mark Details
Serial Number
No 85322909
Mark Type
No Service/Collective Mark
Attorney Docket Number
No GRAD:3003
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 04th May 2015 | ABANDONMENT - NO USE STATEMENT FILED |
| 04th May 2015 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 22nd Oct 2014 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 22nd Oct 2014 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 26th Aug 2014 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 23rd Aug 2014 | EXTENSION 5 GRANTED |
| 21st Aug 2014 | TEAS EXTENSION RECEIVED |
| 21st Aug 2014 | EXTENSION 5 FILED |
| 05th Apr 2014 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 04th Apr 2014 | EXTENSION 4 GRANTED |